Cori Clinical raises $4m seed led by Breega
The financing brings Enzo Ventures, HEARTFELT, Ventures Together and Bynd alongside Breega to expand Cori Clinical’s trial-planning platform.
Financing and next steps
Cori Clinical announced the seed on October 7. The issuer and HEARTFELT’s announcement establish the $4 million amount and Ventures Together participation, correcting the imported EUR figure and Together Fund attribution.
The capital supports delivery capacity, hiring and further clinical and regulatory intelligence development. Dr Emma Ogburn joins as chief clinical officer. At the announcement, Cori reported working with two major enterprise CROs and supporting studies at Erasmus MC.